Contract Research & Services
Contract Research

The Value of Biobetters

Published 11 November 2014 | By PRA Health Sciences

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total global spending on medicines by 2016, and reach an overall market value of $200 billion to $210 billion in 2016, up from $157 billion in 2011.Seven of the top 10 global medicines by spending will be a biologic within the next 5 years.

Available Downloads

The Value of Biobetters